The Heart Attack Guardian, Newest MedicalTechnology in Heart Attack Prevention, from the AngelMed Company.

Heart Attacks! We all know about them. We all will have that lingering fear somewhere within us as we age. The silent killer now has a guardian. Nope, it’s not the that little white aspirin in your medicine cabinet, but it might just tell you when to pop one of those!

It is a new device warns patients before the ‘earthquake’ strikes inside you. The AngelMed Guardian will warn ahead of time by giving a minute by minute electrocardiogram or EKG readings. At Banner Heart Hospital in Mesa Arizona, Dr. Alphonse Ambrosia oversees the study that began last fall (2010). He said “The device is designed for us to monitor people closer to pick up on recurring heart attacks at a quicker rate.” About 1000 patients will receive the AngelMed Guardian nationwide during the three year study. Five have already accepted the procedure. Donna Vicklun is one of them, undergoing the hour long surgery on March 10,2011. She said she feels lucky to be part of the study since having survived three attacks, the last coming in January, and losing all of her siblings to heart problems. She also stated “I was really very apprehensive at first, nut I am still excited about it.” The study will be made available to those over 65 who have had a heart attack or revascularization such as angioplasty or bypass surgery.

The Gauardian is made up of an internal and an external part that is similar to a pager. This pager-like piece provides warning signals marked by an ‘emergency’ or ‘See Dr’ flashing light accompanied by an auditory signal andor vibration signal as well. A button can deactivate the alarm and has a “Do Not Ignore Symptoms” warning. A wire runs from the external piece of the device and is run under the skin ending where the “reader” is attached to the heart.

Founder and President

Robert E. Fischell received his BSME degree from Duke University and MS and ScD degrees from the University of Maryland. Dr. Fischell was employed at the Johns Hopkins University, Applied Physics Laboratory full-time for 25 years and part-time for an additional 13 years. At John’s Hopkins Dr. Fischell was the Chief Engineer of the Space Department where he worked on more than 50 spacecraft. His interests at Johns Hopkins then turned to the invention of new medical devices such as pacemakers and implantable heart defibrillators.

Vice President, Product Assurance and Global Support

Dave has over 30 years of world wide experience testing and supporting complex technical systems. As Vice President of Product Assurance and Global Support for Angel Medical, Dave has responsibility for managing product testing, quality assurance, quality control, clinical and technical field engineering, and information systems.

The AngelMed Guardian has recieved notable recognition such as the CEMark approval for the AngelMed Guardian and the AngelMed Guardian System Wins Medical Design Excellence Award. (April 12, 2010)

For additional information on the ALERTS clinical trial, please visit the Clinical Trials website of the US National Institutes of Health, or contact:

Jonathan Harwood
Chief Operating Officer
Angel Medical Systems
1163 Shrewsbury Ave., Suite E
Shrewsbury, NJ 07702
(732) 542-3111
jharwood@angel-med.com